Stock REGULUS THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Regulus Therapeutics Inc Nasdaq

Equities

US75915K1016

Chart calendar Regulus Therapeutics Inc

fd7f77ff9502e5.LREnuuPGJkdmT6ni5G1cBXR1KiLuMygXcsjFvANY42s.GiBg-KKlXj0wFtOJlw4vcRIzHmu5Z0dNA6GDhS4xtDFAfUyDk5F2IlEgwg~92608f38e0bbad1ea409a568da217ef2

Upcoming events on Regulus Therapeutics Inc

08/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
20/03/2025 Q4 2024 Earnings Release (Projected)
08/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Regulus Therapeutics Inc

24/06/2024 06:00 pm RGLS8429 MAD Phase 1b Study Results Call
16/05/2024 09:30 pm Annual General Meeting
10/05/2024 01:35 am Q1 2024 Earnings Release
01/05/2024 10:30 pm Canaccord Genuity Genetic Medicine for Generalists Webcast Series
22/03/2024 01:35 am Q4 2023 Earnings Release
12/03/2024 06:00 pm Business Update Call
05/01/2024 Investor Meeting After hours
29/11/2023 08:55 pm Evercore ISI HealthCONx Conference
10/11/2023 02:35 am Q3 2023 Earnings Release
20/09/2023 06:00 pm RGLS8429 Phase 1b Study Results Call
11/09/2023 08:30 pm H.C. Wainwright Global Investment Conference
06/09/2023 08:30 pm R&D Day
06/09/2023 Wells Fargo Healthcare Conference
09/08/2023 09:00 pm Canaccord Genuity Growth Conference
09/08/2023 01:35 am Q2 2023 Earnings Release
26/07/2023 12:30 am H.C. Wainwright Kidney Conference
01/06/2023 09:30 pm Annual General Meeting
12/05/2023 01:35 am Q1 2023 Earnings Release
24/03/2023 01:35 am Q4 2022 Earnings Release
09/03/2023 Chronic Kidney Disease Drug Development Summit

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		6,83
6,86
-0.38%		10,0
5,02
99.28%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		-30,9
-30,7
-0.59%
0,00

EBIT
Million USD		Released
Forecast
Spread 		-16,8
-17,2
2.18%		-14,2
-19,2
26.36%		-27,8
-27,4
-1.42%		-28,2
-28,9
2.15%		-31,1
-30,9
-0.82%
-37,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-18,6
-18,9
1.85%		-15,7
-20,9
24.88%		-27,8
-26,9
-3.43%		-28,3
-29,1
2.67%		-30,0
-29,9
-0.47%
-35,4

Net income
Million USD		Released
Forecast
Spread 		-18,6
-18,9
1.85%		-15,7
-20,9
24.86%		-27,8
-26,9
-3.43%		-28,3
-29,1
2.67%		-30,0
-30,0
-0.13%
-34,6

EPS
USD		Released
Forecast
Spread 		-10,8
-11,0
1.82%		-4,50
-6,60
31.82%		-3,20
-3,27
2.04%		-1,86
-1,83
-1.82%		-1,58
-1,59
0.32%
-0,61

Announcement Date12/03/2009/03/2110/03/2223/03/2321/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-6,57
-7,21
8.84%		-7,18
-7,05
-1.77%		-7,56
-7,35
-2.9%		-6,93
-7,66
9.5%		-7,37
-7,08
-4.16%		-7,32
-7,51
2.55%		-8,13
-7,51
-8.19%		-8,30
-8,05
-3.11%		-8,83
-8,70
-1.45%
-8,60


-9,77


-9,77







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,72
-7,20
6.75%		-7,26
-7,14
-1.67%		-7,55
-7,39
-2.13%		-6,80
-7,70
11.75%		-7,14
-6,99
-2.1%		-7,01
-7,34
4.41%		-7,82
-7,31
-6.99%		-8,06
-7,91
-1.94%		-8,47
-8,56
1.05%
-8,24


-9,08


-9,42







Net income
Million USD		Released
Forecast
Spread 		-6,72
-7,20
6.73%		-7,26
-7,14
-1.67%		-7,55
-7,39
-2.13%		-6,80
-7,70
11.75%		-7,14
-6,99
-2.1%		-7,01
-7,34
4.39%		-7,82
-7,31
-6.99%		-8,06
-8,01
-0.7%		-8,47
-8,07
-4.91%
-8,13


-8,79


-9,07







EPS
USD		Released
Forecast
Spread 		-0,50
-0,53
6.25%		-0,50
-0,49
-3.09%		-0,50
-0,49
-2.04%		-0,40
-0,51
21.57%		-0,42
-0,44
3.82%		-0,37
-0,41
9.76%		-0,40
-0,40
-0.84%		-0,40
-0,40
-1.27%		-0,29
-0,22
-30.34%
-0,12


-0,13


-0,14


-0,19


-0,19

Announcement Date12/05/2211/08/2210/11/2223/03/2311/05/2308/08/2309/11/2321/03/2409/05/24-----

Upcoming sector events for Regulus Therapeutics Inc

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Regulus Therapeutics Inc

05/06/2024 01:21 pm PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. RGLS Stock
  4. Stock
  5. Calendar Regulus Therapeutics Inc